You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS
|
|---|---|
| Published in |
Multiple Sclerosis Journal, October 2020
|
| DOI | 10.1177/1352458520969145 |
| Pubmed ID | |
| Authors |
Mikael Cohen, Lydiane Mondot, Florence Bucciarelli, Béatrice Pignolet, David-Axel Laplaud, Sandrine Wiertlewski, Bruno Brochet, Aurélie Ruet, Gilles Defer, Nathalie Derache, Patrick Vermersch, Hélène Zephir, Marc Debouverie, Guillaume Mathey, Eric Berger, Chrystelle Cappé, Pierre Labauge, Clarisse Carra, Jérôme De Seze, Kevin Bigaut, David Brassat, Christine Lebrun-Frenay |
X Demographics
The data shown below were collected from the profiles of 29 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 6 | 21% |
| United States | 4 | 14% |
| Mexico | 3 | 10% |
| Serbia | 1 | 3% |
| Canada | 1 | 3% |
| United Kingdom | 1 | 3% |
| Argentina | 1 | 3% |
| France | 1 | 3% |
| Colombia | 1 | 3% |
| Other | 0 | 0% |
| Unknown | 10 | 34% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 17 | 59% |
| Practitioners (doctors, other healthcare professionals) | 9 | 31% |
| Scientists | 3 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 35 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 5 | 14% |
| Researcher | 4 | 11% |
| Professor | 3 | 9% |
| Student > Master | 3 | 9% |
| Student > Bachelor | 2 | 6% |
| Other | 7 | 20% |
| Unknown | 11 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 12 | 34% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 11% |
| Neuroscience | 4 | 11% |
| Economics, Econometrics and Finance | 1 | 3% |
| Arts and Humanities | 1 | 3% |
| Other | 2 | 6% |
| Unknown | 11 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 33. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 November 2020.
All research outputs
#1,208,314
of 25,374,917 outputs
Outputs from Multiple Sclerosis Journal
#140
of 3,713 outputs
Outputs of similar age
#32,394
of 440,515 outputs
Outputs of similar age from Multiple Sclerosis Journal
#4
of 79 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,713 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.2. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,515 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 79 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.